Metlife Inc. (MET) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
Metlife’s revenue went from $60.8B in fiscal 2016 to $77.1B in fiscal 2025, growth of about 2.7% a year.
Net income in fiscal 2025 was $3.4B, a net margin of 4.4%; the best year in this period was 2021 with $6.9B.
Over the twelve months to September 30, 2026, revenue was $82.6B and net income $5.0B.
Free cash flow was $17.1B in fiscal 2025 and positive in 10 of the 10 years shown.
The diluted share count fell 39% over the period (buybacks).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $82.6B | $77.1B | $71.0B | $66.9B | $68.8B | $68.7B | $67.8B | $69.6B | $67.9B | $62.3B | $60.8B |
| Gross profit | — | — | — | — | — | — | — | — | — | — | — |
| Operating income | $6.7B | $6.1B | $6.0B | $5.7B | $6.0B | — | — | — | — | — | — |
| Net income | $5.0B | $3.4B | $4.4B | $1.6B | $5.3B | $6.9B | $5.4B | $5.9B | $5.1B | $4.0B | $850M |
| EPS (diluted) | $7.67 | $4.71 | $5.94 | $1.81 | $6.30 | $7.65 | $5.68 | $6.06 | $4.91 | $3.62 | $0.67 |
| R&D | — | — | — | — | — | — | — | — | — | — | — |
| Revenue growth | — | +8.6% | +6.1% | −2.7% | +0.1% | +1.3% | −2.5% | +2.5% | +9.0% | +2.5% | −0.9% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $14.0B | $17.1B | $14.6B | $13.7B | $13.0B | $12.3B | $11.6B | $13.8B | $11.7B | $12.3B | $14.8B |
| Capital spending | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Free cash flow | $14.0B | $17.1B | $14.6B | $13.7B | $13.0B | $12.3B | $11.6B | $13.8B | $11.7B | $12.3B | $14.8B |
| Dividends paid | $1.5B | $1.5B | $1.5B | $1.6B | $1.6B | $1.6B | $1.7B | $1.6B | $1.7B | $1.7B | $1.7B |
| Buybacks | $2.6B | $2.9B | $3.2B | $3.1B | $3.3B | $4.3B | $1.2B | $2.3B | $4.0B | $2.9B | $372M |
| Stock-based pay | — | $131M | $168M | $171M | $184M | $173M | $127M | $150M | $86M | $128M | $147M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $25.6B | $25.2B | $26.7B | $25.1B | $27.2B | $23.7B | $20.4B | $19.8B | $17.6B | $19.2B |
| Debt | — | $15.6B | $16.2B | $16.8B | $15.8B | $15.2B | $14.6B | $15.1B | $12.8B | $15.7B | $16.4B |
| Equity | — | $28.4B | $27.4B | $30.0B | $29.9B | $67.5B | $74.6B | $66.1B | $52.7B | $58.7B | $67.5B |
| Total assets | — | $745.2B | $677.5B | $687.6B | $663.1B | $759.7B | $795.1B | $740.5B | $687.5B | $719.9B | $898.8B |
| Shares (diluted) | 640M | 673M | 711M | 762M | 809M | 869M | 913M | 944M | 1.01B | 1.08B | 1.11B |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | — | — | — | — | — | — | — |
| Operating margin | 8.2% | 8.0% | 8.5% | 8.6% | 8.7% | — | — | — | — | — | — |
| Net margin | 6.0% | 4.4% | 6.2% | 2.4% | 7.7% | 10.0% | 8.0% | 8.5% | 7.5% | 6.4% | 1.4% |
| FCF margin | 16.9% | 22.2% | 20.6% | 20.5% | 19.0% | 18.0% | 17.2% | 19.8% | 17.3% | 19.7% | 24.3% |
| ROIC | — | 10.2% | 10.9% | 9.1% | 10.9% | — | — | — | — | — | — |
| ROE | — | 11.9% | 16.1% | 5.3% | 17.7% | 10.2% | 7.2% | 8.9% | 9.7% | 6.8% | 1.3% |
Frequently asked questions
What is Metlife’s annual revenue?
$77.1B in fiscal 2025 and $82.6B over the twelve months to September 30, 2026.
How much profit does Metlife make?
Net income was $3.4B in fiscal 2025 (net margin 4.4%).
Is Metlife’s revenue growing?
Yes: revenue rose 8.6% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.